Business Description
Petlife Pharmaceuticals Inc
NAICS : 325412
SIC : 2834
ISIN : US71639C1036
Compare
Compare
Traded in other countries / regions
PTLF.USA IPO Date
2007-03-08Description
Petlife Pharmaceuticals Inc specializes in the research, development, sales, and support of advanced drugs and nutraceuticals for pet cancer and autoimmune related diseases such as arthritis. It develops potentiated veterinary cancer medications and nutraceuticals, under its tradename Vitalzul based on Escozine formula. The Vitalzul is a polarized, bioactive peptide extracted from the Blue Caribbean Scorpion (Rhopularus Princeps), which contains amino acids, proteins, and minerals.
Financial Strength
| Name | Current | Vs Industry | Vs History |
|---|
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
| Name | Current | Vs Industry | Vs History |
|---|
GF Value Rank
| Name | Current | Vs Industry | Vs History |
|---|
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:PTLF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Petlife Pharmaceuticals Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -0.057 | ||
| Beta | 53.7026 | ||
| 3-Year Sharpe Ratio | 0.14 | ||
| 3-Year Sortino Ratio | 0.23 | ||
| Volatility % | - | ||
| 14-Day RSI | - | ||
| 14-Day ATR ($) | - | ||
| 20-Day SMA ($) | 0.0001 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range ($) | 0.0001 - 0.0001 | ||
| Shares Outstanding (Mil) | 196.75 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Petlife Pharmaceuticals Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Petlife Pharmaceuticals Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| 0.2:1 Stock Split | 2016-09-12 | 0.80 (+0.00%) | ||
| 0.05:1 Stock Split | 2014-08-12 | 6.90 (+97.14%) | ||
| 0.025:1 Stock Split | 2012-07-12 | 28.40 (+1.43%) | ||
| 0.01:1 Stock Split | 2010-10-04 | 29,200.00 (+0.00%) | ||
| 0.014286:1 Stock Split | 2009-09-17 | 84,033.61 (+0.00%) | ||
| 3:1 Stock Split | 2008-02-11 | -- | ||
| 2.5:1 Stock Split | 2007-07-09 | -- |
Show
Entries
Petlife Pharmaceuticals Inc Frequently Asked Questions
What is Petlife Pharmaceuticals Inc(PTLF)'s stock price today?
The current price of PTLF is $0.00. The 52 week high of PTLF is $0.00 and 52 week low is $0.00.
When is next earnings date of Petlife Pharmaceuticals Inc(PTLF)?
The next earnings date of Petlife Pharmaceuticals Inc(PTLF) is .
Does Petlife Pharmaceuticals Inc(PTLF) pay dividends? If so, how much?
Petlife Pharmaceuticals Inc(PTLF) does not pay dividend.
Guru Commentaries on OTCPK:PTLF
No articles.
Press Release
| Subject | Date | ||
|---|---|---|---|
| Byzen Digital Changes Name and Ticker Symbol to Clean Vision Corporation and CLNV; New Name Reflects Ongoing Pivot to Green, Sustainable Technologies | 2021-04-22 |
Articles on Petlife Pharmaceuticals Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers